These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10798998)

  • 1. Metabolic analysis in drug discovery.
    Cárdenas ML; Cornish-Bowden A
    Science; 2000 Apr; 288(5466):618-9. PubMed ID: 10798998
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists.
    Copeland RA
    Methods Biochem Anal; 2005; 46():1-265. PubMed ID: 16350889
    [No Abstract]   [Full Text] [Related]  

  • 3. Made-to-order medicine.
    Begley S
    Newsweek; 2001 Jun; 137(26):64-6, 68-9. PubMed ID: 11436376
    [No Abstract]   [Full Text] [Related]  

  • 4. Next generation chemical proteomic tools for rapid enzyme profiling.
    Uttamchandani M; Lu CH; Yao SQ
    Acc Chem Res; 2009 Aug; 42(8):1183-92. PubMed ID: 19435360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regulation of the functions of the metabolic pathway].
    Duszyński J
    Postepy Biochem; 1983; 29(1):3-15. PubMed ID: 6356098
    [No Abstract]   [Full Text] [Related]  

  • 6. Seeing small molecules in action with bioorthogonal chemistry.
    Raghavan AS; Hang HC
    Drug Discov Today; 2009 Feb; 14(3-4):178-84. PubMed ID: 18973827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human genome project: pharmacogenomics and drug development.
    Ganguly NK; Bano R; Seth SD
    Indian J Exp Biol; 2001 Oct; 39(10):955-61. PubMed ID: 11883519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial genomics and drug discovery: exploring innovative routes of drug discovery in the postgenomic era.
    Dougherty TJ; Miller PF
    IDrugs; 2006 Jun; 9(6):420-2. PubMed ID: 16752312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a novel series of Notch-sparing gamma-secretase inhibitors.
    Kreft A; Harrison B; Aschmies S; Atchison K; Casebier D; Cole DC; Diamantidis G; Ellingboe J; Hauze D; Hu Y; Huryn D; Jin M; Kubrak D; Lu P; Lundquist J; Mann C; Martone R; Moore W; Oganesian A; Porte A; Riddell DR; Sonnenberg-Reines J; Stock JR; Sun SC; Wagner E; Woller K; Xu Z; Zhou H; Steven Jacobsen J
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4232-6. PubMed ID: 18556202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human metabolic network reconstruction and its impact on drug discovery and development.
    Ma H; Goryanin I
    Drug Discov Today; 2008 May; 13(9-10):402-8. PubMed ID: 18468557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scaffold oriented synthesis. Part 1: Design, preparation, and biological evaluation of thienopyrazoles as kinase inhibitors.
    Akritopoulou-Zanze I; Darczak D; Sarris K; Phelan KM; Huth JR; Song D; Johnson EF; Jia Y; Djuric SW
    Bioorg Med Chem Lett; 2006 Jan; 16(1):96-9. PubMed ID: 16216502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Searching for new allosteric sites in enzymes.
    Hardy JA; Wells JA
    Curr Opin Struct Biol; 2004 Dec; 14(6):706-15. PubMed ID: 15582395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery, SAR, and X-ray structure of novel biaryl-based dipeptidyl peptidase IV inhibitors.
    Qiao L; Baumann CA; Crysler CS; Ninan NS; Abad MC; Spurlino JC; Desjarlais RL; Kervinen J; Neeper MP; Bayoumy SS; Williams R; Deckman IC; Dasgupta M; Reed RL; Huebert ND; Tomczuk BE; Moriarty KJ
    Bioorg Med Chem Lett; 2006 Jan; 16(1):123-8. PubMed ID: 16236500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expediting drug discovery: recent advances in fast medicinal chemistry--optimization of hits and leads.
    Edwards PJ; Allart B; Andrews MJ; Clase JA; Menet C
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):425-44. PubMed ID: 16889227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemogenomics: drug discovery's panacea?
    Jacoby E
    Mol Biosyst; 2006 May; 2(5):218-20. PubMed ID: 16880939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and biological evaluation of novel alpha-glucosidase inhibitors with in vivo antidiabetic effect.
    Park H; Hwang KY; Kim YH; Oh KH; Lee JY; Kim K
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3711-5. PubMed ID: 18524587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinatorial compound libraries for drug discovery: an ongoing challenge.
    Geysen HM; Schoenen F; Wagner D; Wagner R
    Nat Rev Drug Discov; 2003 Mar; 2(3):222-30. PubMed ID: 12612648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of potential enzyme targets by metabolic modelling and optimization: application to a simple enzymopathy.
    Vera J; Curto R; Cascante M; Torres NV
    Bioinformatics; 2007 Sep; 23(17):2281-9. PubMed ID: 17586544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-(1H-indazol-5-yl)-6-phenylpyrimidin-2(1H)-one analogs as potent CDC7 inhibitors.
    Shafer CM; Lindvall M; Bellamacina C; Gesner TG; Yabannavar A; Jia W; Lin S; Walter A
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4482-5. PubMed ID: 18672368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity-based ranking of ligands for DPP-4 from mixtures.
    Adam GC; Meng J; Athanasopoulos J; Zhang X; Chapman KT
    Bioorg Med Chem Lett; 2007 May; 17(9):2404-7. PubMed ID: 17337342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.